Autoimmune thyroiditis: A model uniquely suited to probe regulatory T cell function

Journal of Autoimmunity

Volumn 33, Issue 3-4, 2009, Pages 239-246

  Kong, Yi chi M ^a   Morris, Gerald P ^a   Brown, Nicholas K ^a   Yan, Yan ^a   Flynn, Jeffrey C ^a   David, Chella S ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Autoimmune thyroiditis; Circulatory thyroglobulin; Enhancing self tolerance; MHC influence and autoimmunity; Regulatory T cells; Regulatory T cells and autoimmunity; Tolerance augmentation

Indexed keywords

AUTOANTIGEN; THYROGLOBULIN; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL SELECTION; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; CYTOKINES; DISEASE MODELS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 71649114308     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.09.004     Document Type: Article

References (77)

1. Vladutiu A.O., and Rose N.R. Autoimmune murine thyroiditis: relation to histocompatibility (H-2) type. Science 174 (1971) 1137-1139
2. Beisel K.W., David C.S., Giraldo A.A., Kong Y.M., and Rose N.R. Regulation of experimental autoimmune thyroiditis: mapping of susceptibility to the I-A subregion of the mouse H-2. Immunogenetics 15 (1982) 427-431
3. ElRehewy M., Kong Y.M., Giraldo A.A., and Rose N.R. Syngeneic thyroglobulin is immunogenic in good responder mice. Eur J Immunol 11 (1981) 146-151
4. Esquivel P.S., Rose N.R., and Kong Y.M. Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med 145 (1977) 1250-1263
5. Nabozny G.H., and Kong Y.M. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1β. J Immunol 149 (1992) 1086-1092
6. Ikekubo K., Kishihara M., Sanders J., Jutton J., and Schneider A.B. Differences between circulating and tissue thyroglobulin in rats. Endocrinology 109 (1981) 427-432
7. Kong Y.M., Okayasu I., Giraldo A.A., Beisel K.W., Sundick R.S., Rose N.R., et al. Tolerance to thyroglobulin by activating suppressor mechanisms. Ann N Y Acad Sci 392 (1982) 191-209
8. Lewis M., Giraldo A.A., and Kong Y.M. Resistance to experimental autoimmune thyroiditis induced by physiologic manipulation of thyroglobulin level. Clin Immunol Immunopathol 45 (1987) 92-104
9. Rose N.R., Kong Y.M., Okayasu I., Giraldo A.A., Beisel K., and Sundick R.S. T-cell regulation in autoimmune thyroiditis. Immunol Rev 55 (1981) 299-314
10. Kojima A., Tanaka-Kojima Y., Sakakura T., and Nishizuka Y. Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab Invest 34 (1976) 550-557
11. Penhale W.J., Farmer A., and Irvine W.J. Thyroiditis in T cell-depleted rats: influence of strain, radiation dose, adjuvants and antilymphocyte serum. Clin Exp Immunol 21 (1975) 362-375
12. Kojima A., and Prehn R.T. Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 14 (1981) 15-27
13. Sakaguchi S., Takahashi T., and Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 156 (1982) 1565-1576
14. Samy E.T., Setiady Y.Y., Ohno K., Pramoonjago P., Sharp C., and Tung K.S. The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function. Immunol Rev 212 (2006) 170-184
15. Lewis M., Fuller B.E., Giraldo A.A., and Kong Y.M. Resistance to experimental autoimmune thyroiditis is correlated with the duration of raised thyroglobulin levels. Clin Immunol Immunopathol 64 (1992) 197-204
16. Fuller B.E., Okayasu I., Simon L.L., Giraldo A.A., and Kong Y.M. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression. Clin Immunol Immunopathol 69 (1993) 60-68
17. + cells as mediators of both thyroglobulin-activated and TSH-induced suppression. Clin Immunol Immunopathol 51 (1989) 38-54
18. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
19. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184 (1996) 387-396
20. Zheng Y., and Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8 (2007) 457-462
21. + regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell Immunol 226 (2003) 20-29
22. Sakaguchi S., Yamaguchi T., Nomura T., and Ono M. Regulatory T cells and immune tolerance. Cell 133 (2008) 775-787
23. + regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis. J Immunol 174 (2005) 3111-3116
24. + regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun (2009) 68-76
25. Zhang W., Flynn J.C., and Kong Y.M. IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: role of IFN-γ and the costimulatory molecules CD40L and CD28. Cell Immunol 208 (2001) 52-61
26. + T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J Autoimmun 26 (2006) 24-31
27. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16 (2002) 311-323
28. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3 (2002) 135-142
29. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
30. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172 (2004) 5149-5153
31. Fu S., Zhang N., Yopp A.C., Chen D., Mao M., Chen D., et al. TGF-β induces Foxp3 + T-regulatory cells from CD4 + CD25-precursors. Am J Transpl 4 (2004) 1614-1627
32. Zhang W., and Kong Y.M. Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis. Cell Immunol 187 (1998) 95-102
33. Fife B.T., and Bluestone J.A. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224 (2008) 166-182
34. Vasu C., Gorla S.R., Prabhakar B.S., and Holterman M.J. Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. Inter Immunol 15 (2003) 641-654
35. + regulatory cells. J Immunol 176 (2006) 3321-3329
36. + regulatory T cell function. Science 322 (2008) 271-275
37. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 6 (2005) 338-344
38. Tang Q., and Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9 (2008) 239-244
39. + regulatory T cell-depleted mice. Cancer Res 65 (2005) 8471-8478
40. Caturegli P., Vidalain P.O., Vali M., Aguilera-Galaviz L.A., and Rose N.R. Cloning and characterization of murine thyroglobulin cDNA. Clin Immunol Immunopathol 85 (1997) 221-226
41. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., et al. Mice lacking MHC class II molecules. Cell 66 (1991) 1051-1066
42. Wan Q., Shah R., McCormick D.J., Lomo L.C., Giraldo A.A., David C.S., et al. H2-E transgenic class II-negative mice can distinguish self from nonself in susceptibility to heterologous thyroglobulins in autoimmune thyroiditis. Immunogenetics 50 (1999) 22-30
43. Creemers P., Rose N.R., and Kong Y.M. Experimental autoimmune thyroiditis: in vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J Exp Med 157 (1983) 559-571
44. Kong Y.M., Flynn J.C., Wan Q., and David C.S. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity 36 (2003) 397-404
45. + transgenic model susceptible only to heterologous thyroglobulin. Thyroid 12 Suppl. (2002) 117
46. + transgenic model susceptible to human but not mouse thyroglobulin-induced autoimmune thyroiditis: identification of mouse pathogenic epitopes. Cell Immunol 251 (2008) 1-7
47. Flynn J.C., Wan Q., Panos J.C., McCormick D.J., Giraldo A.A., David C.S., et al. Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis. J Autoimmun 18 (2002) 213-220
48. Kong Y.M., David C.S., Lomo L.C., Fuller B.E., Motte R.W., and Giraldo A.A. Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics 46 (1997) 312-317
49. k transgene in B10 mice suppresses the development of myasthenia gravis. Immunogenetics 31 (1990) 241-244
50. Nishimoto H., Kikutani H., Yamamura K., and Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328 (1987) 432-434
51. Flynn J.C., Fuller B.E., Giraldo A.A., Panos J.C., David C.S., and Kong Y.M. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice. J Autoimmun 17 (2001) 7-15
52. Wan Q., Shah R., Panos J.C., Giraldo A.A., David C.S., and Kong Y.M. HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Hum Immunol 63 (2002) 301-310
53. b interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis. J Immunol 180 (2008) 7039-7046
54. g7 molecule. J Immunol 167 (2001) 4104-4114
55. Chaturvedi P., Agrawal B., Zechel M., Lee-Chan E., and Singh B. A self MHC class II β-chain peptide prevents diabetes in nonobese diabetic mice. J Immunol 164 (2000) 6610-6620
56. Das P., Bradley D.S., Geluk A., Griffiths M.M., Luthra H.S., and David C.S. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Hum Immunol 60 (1999) 575-582
57. Rudensky A.Y., Rath S., Preston-Hurlburt P., Murphy D.B., and Janeway Jr. C.A. On the complexity of self. Nature 353 (1991) 660-662
58. Derbinski J., Schulte A., Kyewski B., and Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2 (2001) 1032-1039
59. Heath V.L., Moore N.C., Parnell S.N., and Mason D.W. Intrathymic expression of genes involved in organ specific autoimmune disease. J Autoimmun 11 (1998) 309-318
60. Liston A., Gray D.H.D., Lesage S., Fletcher A.L., Wilson J., Webster K.E., et al. Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med 200 (2004) 1015-1026
61. Misharin A.V., Nagayama Y., Aliesky H.A., Rapoport B., and McLachlan S.M. Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance to thyroid autoantigens. Endocrinology 150 (2009) 2948-2956
62. Kekäläinen E., Tuovinen H., Joensuu J., Gyling M., Franssila R., Pöntynen N., et al. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol 178 (2007) 1208-1215
63. + medullary thymic epithelial cells. Nat Immunol 8 (2007) 351-358
64. Kong YM, Wei W-Z, Tomer Y. Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation. Ann N Y Acad Sci. in press.
65. Kong Y.M., Jacob J.B., Flynn J.C., Elliott B.E., and Wei W.-Z. Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy. Autoimmun Rev 9 (2009) 28-33
66. Mackay I.R., Leskovsek N.V., and Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
67. Shoenfeld Y., Selmi C., Zimlichman E., and Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmmun 31 (2008) 325-330
68. Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., and Mortensen P.B. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29 (2007) 1-9
69. Caturegli P., Lupi I., Landek-Salgado M., Kimura H., and Rose N.R. Pituitary autoimmunity: 30 years later. Autoimmun Rev 7 8 (2008) 631-637
70. Rocchi R., Kimura H., Tzou S.C., Suzuki K., Rose N.R., Pinchera A., et al. Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness. Proc Natl Acad Sci U S A 104 (2007 Apr 3) 6019-6024
71. McGrath-Morrow S., Laube B., Tzou S.C., Cho C., Cleary J., Kimura H., et al. IL-12 overexpression in mice as a model for Sjögren lung disease. Am J Physiol Lung Cell Mol Physiol 291 (2006) L837-L846
72. Brent L., Cohen I.R., Doherty P.C., Feldmann M., Matzinger P., Ghost Lab, et al. Crystal-ball gazing-the future of immunological research viewed from the cutting edge. Clin Exp Immunol 147 (2007) 1-10
73. Njoku D.B., Li Z., Mellerson J.L., Sharma R., Talor M.V., Barat N., et al. IP-10 protects while MIP-2 promotes experimental anesthetic hapten-induced hepatitis. J Autoimmun 32 (2009) 52-59
74. MacGillivray M.H., Mayhew B., and Rose N.R. A comparison of the immunologic function of thymus cells at varying stages of maturation. Proc Soc Exp Biol Med 133 (1970) 688-692
75. Whittingham S., Rowley M.J., and Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 31 (2008) 197-200
76. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 30 (2008) 105-107
77. Blank M., and Gershwin M.E. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4